Chemotherapeutic agents eligible for prior dosing in pancreatic cancer patients requiring hemodialysis: A systematic review

Alexander Hann*, Evelyn Nosalski, Patrick C. Hermann, Jan Egger, Thomas Seufferlein, Frieder Keller

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Chemotherapeutic agents eligible for prior dosing in pancreatic cancer patients requiring hemodialysis: A systematic review'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science